Idrevloride

N/A

Report date: 2023/11/20 20:07:05

NME

Base Information

Drug NameIdrevloride

Drug Alias NameP-1037VX-371GS-5737VRT-1499138VRT1499138

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEpithelial sodium channel blockers

TargetsEpithelial sodium channel

Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCiliary Motility DisordersCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesPoland +[10]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesParion Sciences Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic ObstructiveCiliary Motility DisordersCystic Fibrosis

ATC CodeN/A